Management Team

Simon Holland (age 45) - Non-executive Chairman
Simon  Holland is an independent investment banking consultant, formerly with Midland Montagu Group and Merrill Lynch, and has advised a wide range of companies at different stages in their growth. Simon has been involved in the flotations of a number of companies, including MILS Technology PLC and e-Media C PLC. Until June 2006, he was Chairman of the Dutch investment  banking group Ifex NV. Simon has held non-executive directorships on the boards of a number of companies, including Romtrac PLC and Guards Polo Club Holdings Limited.

Melissa Ehlert (age 44) - Chief Executive Officer
Melissa Ehlert is the founder and former CEO of Pharmaceutical Branding Solutions, Inc (“PBS”). PBS is engaged in developing marketing programs and manufacturing of marketing and educational materials for major pharmaceutical and cosmeceutical companies. Ms. Ehlert has worked in this capacity in the pharmaceutical and cosmeceutical sector for the past 20 years. She has participated in the development of marketing materials for over 57 pharmaceutical drug launches in her career, providing both brand direction and creativity to enhance brand awareness. Ms Ehlert has an extensive background in dermatology, ophthalmology, primary care, neurology, and oncology products as well as consumer and ‘over-the-counter’ products.

David Kingsnorth - Finance Director
David Kingsnorth has extensive finance director and company secretarial expertise combined with a wide experience of working in entrepreneurial environments, both public and private. For the past nine years he has worked for the Weekenders Group, a private international direct selling womenswear wholesaler, where he managed financial and operational affairs of the company within Europe. Originally trained at Ernst & Young, David first moved into property development working for Ford Sellar Morris Group, and was involved in various corporate finance projects including several major takeovers. After a period of working as a consultant to KPMG and various other companies, including a leading womenswear chain, David was then involved in setting up BCG Communications Limited, a 'below-the-line' design and marketing agency..

Robert Mallon (age 61) - Non-executive Director
Robert Mallon has been working as a consultant to major US and European corporations and small growth companies for 25 years. Early in his career, he worked for investment banks in the City of London and on Wall Street, New York. He is a non-executive director of Adomos S.A.

Alexandra Rayner (age 46) - Non-executive Director
Alex has stepped down as CEO, but remains as a non-executive director. Alex has been succeeded by Melissa Ehlert as Chief Executive Officer.

September Bradford Powers  (age 43) -  COO / Director of US Operations
September Powers has extensive experience in the film industry working in production management and business affairs with various companies including the Cannon Group, About Face Productions, Mr Peter Bognanivich and Peters Entertainment. September has also worked in the advertising industry with Asher Gould Advertising on advertising campaigns for Jenny Craig Weight Loss System and Subaru.


  • Plus Market Listing

Transdermal Cosmetics Plc is a company focusing on the production, distribution and commercialisation of cosmetics produced using a technology which facilitates the delivery of a variety of cosmetic substances such as collagen and elastin, which have high density molecular weights, into the skin without causing skin inflammation.
  • Deutsche Borse Listing

Tick data show the continuous price, or index values respectively, as well as the order book turnover from the previous trading day...
  • The mail on Sunday, Dec 2, 2007

A BEAUTY products group that claims to own a revolutionary anti-ageing cream is to float on Lodon's Plus Markets exchange this week with an expected value of about £60milion.
Transdermal Cosmetics , headed by Chief Executive Alexandra Rayner who until recently was retail director at Body Shop produces Entre Derm, which ...
Home   |  Science & Products   |  Investors   |  Media  |   Contact